Cost-effectiveness of the rational use of myocardial perfusion imaging in stable coronary artery disease

VernacularTitle:在稳定性冠心病中合理使用心肌灌注显像的成本效益分析
Author: Lihong YANG ¹ ; Yan ZENG ; Sijin LI
Author Information

1. 山西医科大学第一医院核医学科，太原　030001
Keywords: Coronary disease; Myocardial perfusion imaging; Cost-benefit analysis; Trends
From: Chinese Journal of Nuclear Medicine and Molecular Imaging 2024;44(7):436-439
CountryChina
Language:Chinese
Abstract: China has the highest mortality rate from cardiovascular disease in the world and coronary artery disease (CAD) is the leading cause of death from cardiovascular disease. The cost of treatment for CAD is high, which is related to the incidence of CAD and possible irrational treatment protocols. However, with the escalating costs of healthcare in most countries, the cost-effectiveness of diagnostic and management testing is increasingly important. Many studies have shown that most non-invasive tests are more cost-effective than coronary angiography (CAG). This article reviews the cost-effectiveness of MPI compared with CAG and other non-invasive tests.